Discontinued — last reported Q4 '20
Rollins Business Sale Proceeds increased by 110.6% to $624.00K in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 55.6%, from $1.41M to $624.00K.
An increase signals portfolio optimization or a strategic pivot, while a lack of proceeds suggests a stable, long-term asset base.
This metric represents the cash inflows received from the divestiture or sale of business segments, product lines, or su...
Occurs sporadically; peers often divest legacy segments to focus on high-margin innovation areas like continuous glucose monitoring or diagnostics.
proceeds_from_sale_of_business| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $5.31M | $553.00K | -$70.97M | $1.29M | $2.00M | $6.53M | -$9.82M | $8.89M | $1.30M | $28.00K | $5.69M | $712.00K | $1.60M | $660.00K | -$2.97M | $1.41M | $2.07M | $2.42M | -$5.89M | $624.00K |
| QoQ Change | — | -89.6% | <-999% | +101.8% | +55.0% | +226.6% | -250.4% | +190.5% | -85.4% | -97.8% | >999% | -87.5% | +124.9% | -58.8% | -550.5% | +147.3% | +47.0% | +17.0% | -343.6% | +110.6% |
| YoY Change | — | — | — | — | -62.4% | >999% | +86.2% | +588.8% | -35.0% | -99.6% | +157.9% | -92.0% | +23.2% | >999% | -152.3% | +97.3% | +29.0% | +266.1% | -98.0% | -55.6% |